The increasing global incidence of gastric cancer is a major factor driving the demand for gastric cancer diagnostics. The market is also being fueled by the rising prevalence of GERD and other stomach-related conditions, along […]
Tag: DelveInsight Business Research
Roche’s PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give Tough Competition to AstraZeneca and Other Pharma Companies
Following achievements in Asia, Roche’s PNH treatment drug PIASKY (crovalimab) received its first FDA approval. This approval has spiked the competition between Roche and current market leader AstraZeneca. Additionally, the other pharma companies also geared […]
NRG Fusion Market to Grow at a CAGR of 15% Due to Expected First Launch of Merus’ Zenocutuzumab and Increased Adoption of NRG1 Fusion Biomarker Testing During the Study Period (2020-2034)
According to DelveInsight’s analysis, the growth of the NRG Fusion market is expected to be mainly driven by the expected launch of various emerging therapies, including zenocutuzumab, HMBD-001, JK07, and others along with increased awareness […]
Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030
The increasing demand for cancer monoclonal antibodies is mainly driven by the rising incidence of cancer, the growing prevalence of risk factors like smoking, radiation exposure, unhealthy lifestyles, and other contributing factors. Additionally, the surge […]
Global Anti-Infective Drugs Market is Projected to Cross ~USD 175 Billion by 2030
The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated infections, sexually transmitted diseases (STDs), and respiratory infections. These […]